Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000479984 | SCV000572978 | uncertain significance | not specified | 2017-08-24 | criteria provided, single submitter | clinical testing | The M1916T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The M1916T variant is observed in 37/9786 (0.38%) alleles from individuals of African background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals; however, missense variants in nearby residues have not been reported in the Human Gene Mutation Database in association with nemaline myopathy (Stenson et al., 2014). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. |
EGL Genetic Diagnostics, |
RCV000726779 | SCV000702981 | uncertain significance | not provided | 2016-11-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001087066 | SCV001017474 | likely benign | Nemaline myopathy 2 | 2019-12-31 | criteria provided, single submitter | clinical testing |